Assessment of high-dose acetylcysteine in acute high-risk paracetamol (acetaminophen) ingestion

Clin Toxicol (Phila). 2024 Aug;62(8):519-525. doi: 10.1080/15563650.2024.2377268. Epub 2024 Jul 25.

Abstract

Background: Prompt acetylcysteine treatment with standard doses (300 mg/kg over 21 h in divided doses) is almost universally effective in preventing hepatotoxicity after paracetamol (acetaminophen) overdose. However, hepatotoxicity is reported despite early treatment when paracetamol concentrations exceed 300 mg/L (1,985 μmol/L) at 4 h. Prior studies evaluating high-dose acetylcysteine to treat high-risk ingestions have shown mixed results. We compared outcomes in patients with high-risk ingestions receiving standard or high-dose acetylcysteine.

Methods: Records from a single poison center were reviewed from 1 January 2017 to 31 December 2022. We included cases of acute paracetamol ingestion treated with intravenous acetylcysteine with an initial paracetamol concentration above the "300 mg/L" (1,985 μmol/L) line on the Rumack-Matthew nomogram. We compared standard and high-dose acetylcysteine groups by odds ratios and multivariable logistic regression. We defined hepatotoxicity as aminotransferase activity >1,000 U/L.

Results: We included 190 cases. Fifty-six percent received standard-dose acetylcysteine while 44% received high-dose acetylcysteine. Treatment within 8 h yielded no difference in hepatotoxicity between groups (odds ratio 1.67, 95% CI 0.067-42.3). Among patients treated after 8 h, hepatoxicity was more common in the high-dose group (odds ratio 3.39, 95% CI 1.25-9.2) though odds of liver failure were similar (odds ratio 2.78, 95% CI 0.89-8.69). Eighty-eight percent of patients with hepatotoxicity had elevated aminotransferase activity at presentation. No patient died or received a liver transplant.

Discussion: Rates of hepatotoxicity were low in patients treated within 8 h regardless of acetylcysteine dose. Unexpectedly, high-dose acetylcysteine treatment was associated with an increased odds of hepatoxicity in those treated after 8 h, but most had abnormal aminotransferase activities at presentation and there was no difference in rates of liver failure. Limitations include the use of retrospective, voluntarily reported poison center data.

Conclusions: Prompt treatment with acetylcysteine, regardless of dose, prevented hepatotoxicity in high-risk paracetamol ingestion.

Keywords: Paracetamol; acetaminophen; acetylcysteine; hepatotoxicity; overdose; toxicity.

MeSH terms

  • Acetaminophen* / administration & dosage
  • Acetaminophen* / poisoning
  • Acetylcysteine* / administration & dosage
  • Acetylcysteine* / therapeutic use
  • Adolescent
  • Adult
  • Analgesics, Non-Narcotic / administration & dosage
  • Analgesics, Non-Narcotic / poisoning
  • Antidotes / administration & dosage
  • Antidotes / therapeutic use
  • Chemical and Drug Induced Liver Injury* / etiology
  • Chemical and Drug Induced Liver Injury* / prevention & control
  • Dose-Response Relationship, Drug
  • Drug Overdose* / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Poison Control Centers / statistics & numerical data
  • Retrospective Studies
  • Young Adult

Substances

  • Acetylcysteine
  • Acetaminophen
  • Antidotes
  • Analgesics, Non-Narcotic